SciELO - Scientific Electronic Library Online

 
vol.16 issue3Cytokines, chronic gastritis and Helicobacter pyloriImmunophenotyping in the diagnosis of lympho- and myeloproliferative syndromes author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Hematología, Inmunología y Hemoterapia

Print version ISSN 0864-0289On-line version ISSN 1561-2996

Abstract

GAUTIER DU DEFAIX GOMEZ, Hortensia et al. Evaluation of Trofin in the treatment of iron-deficiency anemia. Rev Cubana Hematol Inmunol Hemoter [online]. 2000, vol.16, n.3, pp.190-197. ISSN 0864-0289.

A comparative evaluation was made between the effectiveness and tolerance of Trofín at doses of 8mg/kg/day and those of ferrous fumarate at the same dosage and by the same route of administration. 40 children aged 6-36 months with iron-deficiency anemia that were randomly divided into 2 groups of treatment, 20 in each group, were studied. A higher increase of the levels of haemoglobin was observed in the group treated with ferrous fumarate. The time of recovery of haemoglobin was significantly longer in the group treated with Trofin. 19 children (95%) treated with ferrous fumarate attained the haemoglobin reference value during the first 3 months of treatment, whereas in the group treated with Trofin,75% reached this value on the fourth month. Trofin was welll tolerated in 90% of the cases. The occurrence of vomiting in 2 children was attributed to a marked rejection to the drug's flavour.The effectiveness of Trofin as an antianaemic drug was good, althought lower than that of ferrous fumarate. Its main inconvenient was the rejection to flavour

Keywords : ANEMIA, IRON-DEFICIENCY [drug therapy]; CHILD; NUTRITIONAL STATUS.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License